Product Information

SEROQUEL XR 50 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $7.7675 per EA under NDC 00310028060. Its NADAC has been published 389 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the quetiapine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

SEROQUEL XR 50 MG TABLET

quetiapine
$7.7675per EA
Discontinued
High Outlier

Strength

50 mg/1

NDC

00310028060

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

3/18/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

New Drug (NDA)

FDA Application

NDA022047

On Market Since

2/1/2009

Pharmacological Classes

Price Statistics

The NADAC for SEROQUEL XR 50 MG TABLET has been published 389 times since Nov 28, 2013, and over the history we have for it it has risen 24.3%. The table below summarizes its recorded NADAC range and movement.

Current price$7.7675 per EA
All-time high$7.9534 (May 15, 2019)
All-time low$6.2016 (Dec 18, 2013)
52-week high$7.9001
52-week low$7.7378
Median price$7.8786
Average price$7.6516
Largest weekly change+10.0% (Jan 8, 2014)
Weeks tracked389
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-1.1%

1Y

-1.5%

3Y

-2.3%

5Y

-2.3%

All

+24.3%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SEROQUEL XR 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SEROQUEL XR 50 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $7.7675 per EA (NDC 00310028060), effective Apr 1, 2026.

How has the price of SEROQUEL XR 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for SEROQUEL XR 50 MG TABLET has risen 24.3%. It has been tracked across 389 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SEROQUEL XR 50 MG TABLET?

Since Nov 28, 2013, the NADAC for SEROQUEL XR 50 MG TABLET has ranged from a low of $6.2016 (Dec 18, 2013) to a high of $7.9534 (May 15, 2019), with a median of $7.8786 per EA.

Are there cheaper alternatives to SEROQUEL XR 50 MG TABLET?

Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QUETIAPINE FUMARATE 50 MG TAB, is $0.0302 per EA — about 100% below SEROQUEL XR 50 MG TABLET.

Who manufactures SEROQUEL XR 50 MG TABLET?

SEROQUEL XR 50 MG TABLET (NDC 00310028060) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.